Manage settings
MENU
About this site
In het Nederlands
Home
Researchers
Projects
Organisations
Publications
Infrastructure
Contact
Research Explorer
Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.
Researcher
Bart Jacobs
Profile
Projects
Publications
Activities
Awards & Distinctions
7
Results
2025
Safety and immunogenicity of an adjuvanted clostridioides difficile vaccine candidate in healthy adults : a randomized placebo-controlled phase 1 study
Isabel Leroux-Roels
Azhar Alhatemi
Magalie Caubet
Fien De Boever
Bertrand de Wergifosse
Mohamed El Idrissi
Guilherme S Ferreira
Bart Jacobs
Axel Lambert
Sandra Morel
et al.
A1
Journal Article
in
JOURNAL OF INFECTIOUS DISEASES
2025
2024
Safety and immunogenicity of a 4-component generalized modules for membrane antigens Shigella vaccine in healthy European adults : randomized, phase 1/2 study
Isabel Leroux-Roels
Cathy Maes
Francesca Mancini
Bart Jacobs
Eleanna Sarakinou
Azhar Alhatemi
Jasper Joye
Silvia Grappi
Giulia Luna Cilio
Alimamy Serry-Bangura
et al.
A1
Journal Article
in
JOURNAL OF INFECTIOUS DISEASES
2024
Safety and immunogenicity of a carbohydrate fatty acid monosulphate ester adjuvant combined with a low-dose quadrivalent split-virion inactivated influenza vaccine : a randomised, observer-blind, active-controlled, first-in-human, phase 1 study
Valentino D'Onofrio
Sharon Porrez
Bart Jacobs
Azhar Alhatemi
Fien De Boever
Gwenn Waerlop
Els Michels
Francesca Vanni
Alessandro Manenti
Geert Leroux-Roels
et al.
A1
Journal Article
in
VACCINES
2024
Safety and immunogenicity of the live-attenuated hRVFV-4s vaccine against Rift Valley fever in healthy adults : a dose-escalation, placebo-controlled, first-in-human, phase 1 randomised clinical trial
Isabel Leroux-Roels
Chittappen Kandiyil Prajeeth
Amare Aregay
Niranjana Nair
Guus F Rimmelzwaan
Albert D M E Osterhaus
Simone Kardinahl
Sabrina Pelz
Stephan Bauer
Valentino D'Onofrio
et al.
A1
Journal Article
in
LANCET INFECTIOUS DISEASES
2024
2023
Immune responses in healthy adults elicited by a bivalent norovirus vaccine candidate composed of GI.4 and GII.4 VLPs without adjuvant
Gwenn Waerlop
Yorick Janssens
Bart Jacobs
Franziska Jarczowski
André Diessner
Geert Leroux-Roels
Victor Klimyuk
Isabel Leroux-Roels
Frank Thieme
A1
Journal Article
in
FRONTIERS IN IMMUNOLOGY
2023
Immunogenicity, safety, and preliminary efficacy evaluation of OVX836, a nucleoprotein-based universal influenza A vaccine candidate : a randomised, double-blind, placebo-controlled, phase 2a trial
Isabel Leroux-Roels
Paul Willems
Gwenn Waerlop
Yorick Janssens
Jessika Tourneur
Fien De Boever
Jacques Bruhwyler
Azhar Alhatemi
Bart Jacobs
Florence Nicolas
et al.
A1
Journal Article
in
LANCET INFECTIOUS DISEASES
2023
2022
A randomized, double-blind, placebo-controlled, dose-escalating phase I trial to evaluate safety and immunogenicity of a plant-produced, bivalent, recombinant norovirus-like particle vaccine
Isabel Leroux-Roels
Cathy Maes
Jasper Joye
Bart Jacobs
Franziska Jarczowski
André Diessner
Yorick Janssens
Gwenn Waerlop
Kirsi Tamminen
Suvi Heinimäki
et al.
A1
Journal Article
in
FRONTIERS IN IMMUNOLOGY
2022